Scapa Healthcare will buy the Systagenix facility in Gargrave, England, from Acelity, Scapa announced this week.
The deal includes manufacturing operations, sterilization services, warehouse facilities, R&D and regulatory support functions located in Gargrave. Scapa and Acelity will also enter into a long-term manufacturing and supply agreement for the advanced wound dressings offered by KCI, an Acelity company, manufactured in Gargrave. Financial terms were not disclosed.
Get the full story on our sister site, Medical Design & Outsourcing.
The post Scapa to buy an Acelity wound-dressing facility in England appeared first on MassDevice.
from MassDevice https://ift.tt/2OjJ5pY
Cap comentari:
Publica un comentari a l'entrada